AGP Picks
View all

Global Wellness Times
Provided by AGP

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on July 23, 2026

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
Jul. 23, 2026

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience
Jul. 23, 2026

VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience

Indeterminate GlobeNewswire
Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026
Jul. 23, 2026

Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026

Indeterminate GlobeNewswire
The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast
Jul. 23, 2026

The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Jul. 23, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Peloton Interactive, Inc. Announces Date of Fourth Quarter & Fiscal Year 2026 Earnings Release and Conference Call
Jul. 23, 2026

Peloton Interactive, Inc. Announces Date of Fourth Quarter & Fiscal Year 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire
Codexis Announces Proposed Public Offering of Common Stock
Jul. 23, 2026

Codexis Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Dr. Shukairo "Shay" Baker to Appear on Impact Makers TV
Jul. 23, 2026

Dr. Shukairo "Shay" Baker to Appear on Impact Makers TV

Indeterminate EIN Presswire
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul. 23, 2026

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Indeterminate GlobeNewswire
Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés
Jul. 23, 2026

Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés

Indeterminate GlobeNewswire
Nature’s Sunshine Sets Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 5:00 p.m. ET
Jul. 23, 2026

Nature’s Sunshine Sets Second Quarter 2026 Conference Call for Thursday, August 6, 2026, at 5:00 p.m. ET

Indeterminate GlobeNewswire
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Jul. 23, 2026

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire
Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
Jul. 23, 2026

Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Jul. 23, 2026

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
Jul. 23, 2026

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Jul. 23, 2026

Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026
Jul. 23, 2026

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
Jul. 23, 2026

Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
Jul. 23, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

Indeterminate GlobeNewswire
Cytokinetics to Announce Second Quarter Results on August 6, 2026
Jul. 23, 2026

Cytokinetics to Announce Second Quarter Results on August 6, 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.